Ranitidine

Product Used For Unknown Indication	32.8%
Drug Use For Unknown Indication	14.8%
Gastrooesophageal Reflux Disease	12.7%
Dyspepsia	5.9%
Prophylaxis	5.9%
Premedication	3.4%
Immunosuppressant Drug Therapy	3.2%
Testicular Germ Cell Tumour Mixed Stage Iii	2.4%
Hypertension	2.0%
Cardiac Disorder	1.7%
Drug Exposure During Pregnancy	1.7%
Pain	1.6%
Anaesthesia Procedure	1.5%
Induction Of Anaesthesia	1.5%
Thrombosis Prophylaxis	1.5%
Angioedema	1.5%
Osteoporosis	1.5%
Ovarian Cancer	1.5%
Abdominal Pain	1.4%
Gastritis	1.4%

Drug Ineffective	9.4%
Urticaria	8.5%
Vomiting	8.5%
Anaphylactic Reaction	7.5%
Renal Failure Acute	6.5%
Nausea	5.9%
Sepsis	5.5%
Thrombocytopenia	5.2%
Tubulointerstitial Nephritis	4.9%
Tremor	4.6%
Drug Interaction	4.2%
Drug Screen Positive	3.9%
Dyspnoea	3.6%
Ventricular Arrhythmia	3.6%
Neutropenia	3.3%
Rash Pruritic	3.3%
Hypotension	2.9%
Rash	2.9%
Stevens-johnson Syndrome	2.9%
Tachycardia	2.9%

Secondary

Product Used For Unknown Indication	31.0%
Drug Use For Unknown Indication	21.7%
Prophylaxis	5.9%
Premedication	4.8%
Gastrooesophageal Reflux Disease	4.5%
Breast Cancer	4.1%
Hypertension	3.4%
Germ Cell Cancer	2.8%
Completed Suicide	2.7%
Pain	2.7%
Drug Exposure During Pregnancy	2.1%
Anaesthesia	2.0%
Diabetes Mellitus	1.9%
Hyperemesis Gravidarum	1.9%
Nausea	1.7%
Chemotherapy	1.5%
Dyspepsia	1.5%
Hepatic Mass	1.3%
Acute Myocardial Infarction	1.3%
Neoplasm Malignant	1.2%

Overdose	10.2%
Completed Suicide	9.2%
Vomiting	8.5%
Drug Ineffective	7.9%
Tubulointerstitial Nephritis	6.6%
Dyspnoea	5.2%
Loss Of Consciousness	5.2%
Urticaria	4.9%
Lower Respiratory Tract Infection	4.3%
Rash	4.3%
Respiratory Arrest	3.9%
Urinary Tract Infection	3.9%
Erectile Dysfunction	3.6%
Thrombocytopenia	3.6%
Myalgia	3.3%
Stevens-johnson Syndrome	3.3%
Wheezing	3.3%
Anaphylactic Reaction	3.0%
Intentional Overdose	3.0%
Maternal Exposure During Pregnancy	3.0%

Concomitant

Product Used For Unknown Indication	31.0%
Drug Use For Unknown Indication	17.5%
Hypertension	6.7%
Prophylaxis	5.4%
Pain	5.2%
Gastrooesophageal Reflux Disease	4.7%
Rheumatoid Arthritis	4.6%
Depression	3.3%
Premedication	3.0%
Diabetes Mellitus	2.4%
Breast Cancer	2.0%
Anxiety	1.8%
Nausea	1.7%
Asthma	1.7%
Non-small Cell Lung Cancer	1.6%
Multiple Myeloma	1.6%
Dyspepsia	1.5%
Blood Cholesterol Increased	1.5%
Hiv Infection	1.4%
Chronic Obstructive Pulmonary Disease	1.3%

Vomiting	17.1%
Weight Decreased	11.0%
Weight Increased	5.9%
Thrombocytopenia	4.9%
Pneumonia	4.9%
Death	4.5%
Nausea	4.4%
Pain	4.4%
Myocardial Infarction	4.2%
Urinary Tract Infection	4.1%
Pulmonary Embolism	4.1%
Vision Blurred	3.6%
Rash	3.5%
Dyspnoea	3.5%
Pyrexia	3.4%
Sepsis	3.4%
Renal Failure Acute	3.3%
Tremor	3.3%
Urticaria	3.2%
White Blood Cell Count Decreased	3.2%

Interacting

Anaesthesia Procedure	14.5%
Product Used For Unknown Indication	14.5%
Drug Use For Unknown Indication	12.7%
Torsade De Pointes	8.1%
Gastrooesophageal Reflux Disease	6.9%
Haematoma Infection	6.9%
Depression	6.4%
Pain	5.8%
Acute Myocardial Infarction	4.6%
Diabetes Mellitus	4.0%
Dyspepsia	2.9%
Prophylaxis Of Nausea And Vomiting	2.3%
Hypertension	1.7%
Pruritus Genital	1.7%
Gastrinoma	1.2%
Hypokalaemia	1.2%
Hypomagnesaemia	1.2%
Irritable Bowel Syndrome	1.2%
Nausea	1.2%
Smoking Cessation Therapy	1.2%

Drug Interaction	18.2%
Sedation	18.2%
Tremor	9.1%
International Normalised Ratio Increased	6.1%
Torsade De Pointes	6.1%
Vomiting	6.1%
Advanced Sleep Phase	3.0%
Atrioventricular Dissociation	3.0%
Drug Effect Decreased	3.0%
Drug Toxicity	3.0%
Drug-induced Liver Injury	3.0%
Exposure During Pregnancy	3.0%
Hyperhidrosis	3.0%
Injection Site Pain	3.0%
Myocarditis	3.0%
Neutropenia	3.0%
Rhabdomyolysis	3.0%
Unevaluable Event	3.0%